Prevalence of advanced hepatic fibrosis and individualization of associated risk factors by Bayesian analysis in MASLD patients in French cardio-metabolic health networks.
The aim of this study was to determine the prevalence of advanced hepatic fibrosis and to individualize using Bayesian analysis its associated risk factors in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) being cared for in three Alsatian cardio-metabolic health netw...
Saved in:
Main Authors: | Michel Doffoel, Frédéric Chaffraix, Archia Chahard, Dominique Gras, Odile Bonomi, Corinne Bildstein, Simona Tripon, Maude Royant, Nicolas Meyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316158 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD
by: Andrew D Schreiner, et al.
Published: (2024-07-01) -
Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study.
by: Wenying Guo, et al.
Published: (2024-01-01) -
Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
by: Antonio Liguori, et al.
Published: (2025-01-01) -
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
by: Shan Hong, et al.
Published: (2025-01-01) -
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
by: Fabrizio Termite, et al.
Published: (2025-01-01)